Benchmark Downgrades Nephros (NEPH) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts NEPH Hot Sheet
Price: $3.53 +0.28%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
Benchmark analyst Robert Wasserman downgraded Nephros (NASDAQ: NEPH) from Speculative Buy to Hold.
For an analyst ratings summary and ratings history on Nephros click here. For more ratings news on Nephros click here.
Shares of Nephros closed at $2.21 yesterday.
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- JPMorgan Downgrades Nick Scali Limited (NCK:AU) to Underweight
- Morgan Stanley Downgrades LG Display Co Ltd. (034220:KS) (LPL) to Underweight
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
